Asthenia: Clinical Trials

3 trials for Asthenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow Asthenia: new trials by email Literature Review of Asthenia trials Research Report on Asthenia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia
Nuvastatic TM (C5OSEW5050ESA) 1000 mg - Asthenia, Cancer
Phase 2 / Phase 3CompletedNatureceuticals Sdn Bhd1102017-09-022020-09-16
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
Droxidopa, Placebo - Orthostatic Hypotension, Parkinson's Disease
Phase 3CompletedChelsea Therapeutics2252010-06-012014-05-20
Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
Coenzyme Q10, Placebo - Pain, Weakness
Phase 2 / Phase 3CompletedCatherine Buettner682009-12-012017-01-23

Narrower conditions

Dizziness (1)  ·  Fatigue (1)  ·  Hypotension, Orthostatic (1)  ·  Muscle Cramp (1)  ·  Muscle Weakness (1)  ·  Myalgia (1)  ·  Myositis, Inclusion Body (1)  ·  Neck Pain (1)  ·  Neoplasms (1)  ·  Pain (1)  ·  Parkinson Disease (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Autonomic Nervous System Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Hypotension (1)  ·  Movement Disorders (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Musculoskeletal Pain (1)  ·  Myositis (1)

Interventions

Droxidopa (1)  ·  Mannitol (1)  ·  Sugars (1)  ·  coenzyme Q10 (1)

Sponsors

Catherine Buettner (1)  ·  Chelsea Therapeutics (1)  ·  Natureceuticals Sdn Bhd (1)

Countries

United States (2)  ·  India (1)

Top investigators

Catherine Buettner, MD, MPH (1)  ·  Ghanashyam Biswas, PHD (1)  ·  Lawrence A. Hewitt, Ph.D. (1)  ·  Robert Hauser, M.D. (1)  ·  William Schwieterman, M.D. (1)

Results publications

PMID 24326693, PMID 27538531, PMID 28494751, PMID 30003579, PMID 38710920

NIH funding

K23AR055664 (1)